{"id":81624,"date":"2022-11-02T05:25:44","date_gmt":"2022-11-02T05:25:44","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=101330"},"modified":"2022-11-02T05:25:44","modified_gmt":"2022-11-02T05:25:44","slug":"ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab","status":"publish","type":"post","link":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/","title":{"rendered":"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB"},"content":{"rendered":"
\n

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) —<\/p>\n

WHY: <\/strong>Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public.<\/p>\n

SO WHAT:<\/strong> If you purchased Y-mAbs securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.<\/p>\n

WHAT TO DO NEXT: <\/strong>To join the prospective class action, go to https:\/\/rosenlegal.com\/submit-form\/?case_id=9496<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com<\/a> or cases@rosenlegal.com<\/a> for information on the class action.<\/p>\n

WHAT IS THIS ABOUT: <\/strong>On October 31, 2022, Marketwatch<\/em> published an article entitled \u201cY-mAbs Therapeutics shares fall 42% following last week\u2019s FDA advisory committee vote\u201d which stated \u201c[s]hares of Y-mAbs Therapeutics Inc. YMAB, [] plunged 42.5% in premarket trading on Monday after several banks downgraded the company\u2019s stock and a Food and Drug Administration advisory committee voted against approval of the company’s experimental treatment for neuroblastoma patients.\u201d<\/p>\n

The article further stated that the \u201ccommittee on Friday voted 16-0 that there wasn\u2019t enough evidence to say that omburtamab improves overall survival. J.P. Morgan downgraded the stock to underweight from neutral, with analysts saying: \u2018We do not think recent newsflow bodes well for investor confidence or for ascribing further pipeline value to follow-on indications which are mostly in their early innings of development.\u2019\u201d<\/p>\n

On this news, Y-mAbs\u2019 stock fell sharply during pre-market and intraday trading on October 31, 2022.<\/p>\n

WHY ROSEN LAW: <\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n

Follow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter: https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

Contact Information:<\/p>\n

\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Laurence Rosen, Esq.
\nPhillip Kim, Esq.
\nThe Rosen Law Firm, P.A.
\n275 Madison Avenue, 40th Floor
\nNew York, NY 10016
\nTel: (212) 686-1060
\nToll Free: (866) 767-3653
\nFax: (212) 202-3827
\nlrosen@rosenlegal.com<\/a>
\npkim@rosenlegal.com<\/a>
\ncases@rosenlegal.com<\/a>
\nwww.rosenlegal.com<\/a><\/p>\n<\/div>\n

GlobeNewswire Distribution ID 8686993<\/p>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public. SO WHAT: If you [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[17,53,343],"tags":[],"yoast_head":"\nYMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB - Lebanon News Gazette<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB - Lebanon News Gazette\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public. SO WHAT: If you [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\" \/>\n<meta property=\"og:site_name\" content=\"Lebanon News Gazette\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-02T05:25:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=\" \/>\n<meta name=\"author\" content=\"lnadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"lnadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\"},\"author\":{\"name\":\"lnadmin\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840\"},\"headline\":\"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB\",\"datePublished\":\"2022-11-02T05:25:44+00:00\",\"dateModified\":\"2022-11-02T05:25:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\"},\"wordCount\":545,\"publisher\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=\",\"articleSection\":[\"MENA\",\"Pakistan\",\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\",\"url\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\",\"name\":\"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB - Lebanon News Gazette\",\"isPartOf\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=\",\"datePublished\":\"2022-11-02T05:25:44+00:00\",\"dateModified\":\"2022-11-02T05:25:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage\",\"url\":\"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=\",\"contentUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lebanonnewsgazette.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#website\",\"url\":\"https:\/\/lebanonnewsgazette.com\/\",\"name\":\"Lebanon News Gazette\",\"description\":\"News from Lebanon\",\"publisher\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lebanonnewsgazette.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#organization\",\"name\":\"Lebanon News Gazette\",\"url\":\"https:\/\/lebanonnewsgazette.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png\",\"contentUrl\":\"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png\",\"width\":503,\"height\":261,\"caption\":\"Lebanon News Gazette\"},\"image\":{\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840\",\"name\":\"lnadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"lnadmin\"},\"url\":\"https:\/\/lebanonnewsgazette.com\/author\/lnadmin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB - Lebanon News Gazette","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/","og_locale":"en_US","og_type":"article","og_title":"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB - Lebanon News Gazette","og_description":"NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) resulting from allegations that Y-mAbs may have issued materially misleading business information to the investing public. SO WHAT: If you [\u2026]","og_url":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/","og_site_name":"Lebanon News Gazette","article_published_time":"2022-11-02T05:25:44+00:00","og_image":[{"url":"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE="}],"author":"lnadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"lnadmin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#article","isPartOf":{"@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/"},"author":{"name":"lnadmin","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840"},"headline":"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB","datePublished":"2022-11-02T05:25:44+00:00","dateModified":"2022-11-02T05:25:44+00:00","mainEntityOfPage":{"@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/"},"wordCount":545,"publisher":{"@id":"https:\/\/lebanonnewsgazette.com\/#organization"},"image":{"@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage"},"thumbnailUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=","articleSection":["MENA","Pakistan","Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/","url":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/","name":"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB - Lebanon News Gazette","isPartOf":{"@id":"https:\/\/lebanonnewsgazette.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage"},"image":{"@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage"},"thumbnailUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=","datePublished":"2022-11-02T05:25:44+00:00","dateModified":"2022-11-02T05:25:44+00:00","breadcrumb":{"@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#primaryimage","url":"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE=","contentUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/berMytv86UKpDgtYPpHYCXvivHtFBXUZKRnp75TlXe3MipMUHrZU__UUl2VzJBEvwK4HPr5oyM3WzeDOyMk8j_R1APxkNSsYuedRLzHWyjjZCo19Mjm7MYTTXpnaEfEs=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY4Njk5MyM1MjM3NTYyIzIwMjA0MTE="},{"@type":"BreadcrumbList","@id":"https:\/\/lebanonnewsgazette.com\/ymab-equity-alert-rosen-global-investor-counsel-encourages-y-mabs-therapeutics-inc-investors-with-losses-to-inquire-about-securities-class-action-investigation-ymab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lebanonnewsgazette.com\/"},{"@type":"ListItem","position":2,"name":"YMAB EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Y-mAbs Therapeutics, Inc. Investors with Losses to Inquire About Securities Class Action Investigation \u2013 YMAB"}]},{"@type":"WebSite","@id":"https:\/\/lebanonnewsgazette.com\/#website","url":"https:\/\/lebanonnewsgazette.com\/","name":"Lebanon News Gazette","description":"News from Lebanon","publisher":{"@id":"https:\/\/lebanonnewsgazette.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lebanonnewsgazette.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/lebanonnewsgazette.com\/#organization","name":"Lebanon News Gazette","url":"https:\/\/lebanonnewsgazette.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/","url":"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png","contentUrl":"https:\/\/lebanonnewsgazette.com\/wp-content\/uploads\/2020\/07\/cropped-lebanonnewsgazette-logo-1.png","width":503,"height":261,"caption":"Lebanon News Gazette"},"image":{"@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/b220111f97227f75d2130729cf3e0840","name":"lnadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lebanonnewsgazette.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"lnadmin"},"url":"https:\/\/lebanonnewsgazette.com\/author\/lnadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/posts\/81624"}],"collection":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/comments?post=81624"}],"version-history":[{"count":0,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/posts\/81624\/revisions"}],"wp:attachment":[{"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/media?parent=81624"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/categories?post=81624"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lebanonnewsgazette.com\/wp-json\/wp\/v2\/tags?post=81624"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}